Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20009184 | 0.86 | GBA1 (0.37) | PER2CRY2 | |
| SCHEMBL20009180 | 0.78 | CYP3A4 (0.32) | PER2CRY2 | |
| SCHEMBL19990608 | 0.70 | ATM (0.31) | — | |
| SCHEMBL21981531 | 0.70 | ATM (0.31) | — | |
| SCHEMBL20158391 | 0.69 | — | — | |
| SCHEMBL22236868 | 0.66 | GBA1 (0.49) | — | |
| SCHEMBL14178601 | 0.65 | BRD4 (0.30) | — | |
| SCHEMBL29312341 | 0.65 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL14218297 | 0.62 | LMNA (0.37) | — | |
| SCHEMBL21621796 | 0.62 | CRBN (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180086762-A1 | BETA-LACTAMASE INHIBITORS | NOVARTIS AG (CH) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180086762-A1 | BETA-LACTAMASE INHIBITORS | MGAM, LCT, GAA | PER2 3451/4885CRY2 2818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.